GPX2 and breast cancer: Our recent work highlights the profound effects of redox signalling by GPx2 KD on the mammary tumour phenotype involving ROS/HIF1α signalling, causing vascular malfunction, resulting in hypoxia and metabolic plasticity [9, 10].